CN116286462A - Lactobacillus plantarum with comprehensive performance in motion improvement and application thereof - Google Patents
Lactobacillus plantarum with comprehensive performance in motion improvement and application thereof Download PDFInfo
- Publication number
- CN116286462A CN116286462A CN202211589419.6A CN202211589419A CN116286462A CN 116286462 A CN116286462 A CN 116286462A CN 202211589419 A CN202211589419 A CN 202211589419A CN 116286462 A CN116286462 A CN 116286462A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus plantarum
- improving
- test
- muscle
- exercise
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000006024 Lactobacillus plantarum Species 0.000 title claims abstract description 26
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title claims abstract description 26
- 229940072205 lactobacillus plantarum Drugs 0.000 title claims abstract description 26
- 230000006872 improvement Effects 0.000 title description 3
- 108010084695 Pea Proteins Proteins 0.000 claims abstract description 14
- 235000019702 pea protein Nutrition 0.000 claims abstract description 14
- 238000004321 preservation Methods 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 238000009629 microbiological culture Methods 0.000 claims abstract description 6
- 235000013305 food Nutrition 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 2
- 210000003205 muscle Anatomy 0.000 abstract description 34
- 150000001413 amino acids Chemical class 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 4
- 238000012360 testing method Methods 0.000 description 32
- 206010016256 fatigue Diseases 0.000 description 17
- 238000012549 training Methods 0.000 description 10
- 239000000523 sample Substances 0.000 description 9
- 102100030840 AT-rich interactive domain-containing protein 4B Human genes 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 101000792935 Homo sapiens AT-rich interactive domain-containing protein 4B Proteins 0.000 description 6
- 238000000585 Mann–Whitney U test Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 210000003195 fascia Anatomy 0.000 description 6
- 230000037182 bone density Effects 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 238000000692 Student's t-test Methods 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000009469 supplementation Effects 0.000 description 4
- 238000012762 unpaired Student’s t-test Methods 0.000 description 4
- NIUAGEVCVWHMTA-UHFFFAOYSA-N 5-(4-iodophenyl)-1-(4-methylsulfonylphenyl)-3-(trifluoromethyl)pyrazole Chemical compound C1=CC(S(=O)(=O)C)=CC=C1N1C(C=2C=CC(I)=CC=2)=CC(C(F)(F)F)=N1 NIUAGEVCVWHMTA-UHFFFAOYSA-N 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 230000037147 athletic performance Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000006041 probiotic Substances 0.000 description 3
- 235000018291 probiotics Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000008934 Muscle Proteins Human genes 0.000 description 2
- 108010074084 Muscle Proteins Proteins 0.000 description 2
- 238000001793 Wilcoxon signed-rank test Methods 0.000 description 2
- 210000002659 acromion Anatomy 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000000386 athletic effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000004417 patella Anatomy 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 210000003314 quadriceps muscle Anatomy 0.000 description 2
- 230000007115 recruitment Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000037487 Endotoxemia Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 241000721701 Lynx Species 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 238000011976 chest X-ray Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 238000009547 dual-energy X-ray absorptiometry Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000032297 kinesis Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 238000007488 musculoskeletal ultrasound Methods 0.000 description 1
- 208000018360 neuromuscular disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000036314 physical performance Effects 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009323 psychological health Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000009192 sprinting Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 238000001946 ultra-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a lactobacillus plantarum (Lactobacillus plantarum) TWK10 with comprehensive performance in the aspect of improving exercise, which is characterized in that the strain is preserved in China general microbiological culture Collection center (China center for type culture Collection) at the year of 2022, 6 and 27, and the preservation address is the North Chen West Lu No. 1, 3 in the Chaoyang area of Beijing city, and the preservation number is CGMCC No.25190. And mixing the lactobacillus plantarum with pea protein to prepare the composition. The composition has the effects of improving amino acid absorption rate, improving anaerobic power and muscle strength, and improving body constitution and muscle mass.
Description
Technical Field
The invention relates to lactobacillus plantarum, in particular to lactobacillus plantarum with comprehensive performance in the aspect of improving exercise and application thereof. Belongs to the technical field of biological medicine processing.
Background
In addition to scientific and bitter training, the physical performance requirements of athletes are higher and higher, and the athletes must have reasonable nutritional support, and long-term high-strength or excessive exercise training, unreasonable nutrition, rest and the like can lead the athletes to generate high stress and high metabolism, and the athletes must have higher tissue and organ adaptability and energy metabolism level, otherwise, various adverse physical and psychological health problems such as infection, asthma, gastrointestinal diseases, inflammatory disorder, immunosuppression, oxidative stress, chronic fatigue, depression anxiety and the like can be induced, and especially in the athletes with three long-distance items such as marathons, super-endurance and iron men, gastrointestinal dysfunction, endotoxemia and the like become important negative factors for affecting the health of the athletes and finally affecting athletic performance.
For people engaged in high exercise, it is often necessary to supplement a large amount of protein in order to maintain and enhance muscle strength, repair damaged muscle proteins. The protein-supplementing sports nutritional food takes protein or protein hydrolysate as a main component, aims to enhance the immunity of human bodies, improve the antioxidant capacity, promote the synthesis of skeletal muscle protein, inhibit muscle decomposition and accelerate the recovery of physical energy after training, and is an ideal sports nutritional food. There are different protein supplementation strategies depending on the type of protein and different sports.
The microorganisms in human bodies are various and have a number of trillions, and part of the microorganisms are beneficial to the health of the human bodies, and are called probiotics, and mainly play a role in maintaining the balance of the human bodies. The probiotics can be used as nutritional supplements for preventing or alleviating respiratory tract infections and gastrointestinal symptoms in athletes, thereby promoting healthy physical development in athletes.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide lactobacillus plantarum with comprehensive performance in the aspect of improving exercise and application thereof.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
lactobacillus plantarum (Lactobacillus plantarum) TWK10 (also called lactobacillus plantarum (Lactiplantibacillus plantarum) TWK 10) with comprehensive performance in motion improvement, which is preserved in China general microbiological culture Collection center (China center for type culture Collection) for 2022, 6 and 27 days, and has a preservation address of Beijing, chaoyang area, north Chen West Lu No. 1, 3 and a preservation number of CGMCC No.25190.
( And (3) injection: the "Commission Wei Jian" requirements for update of the "food-available strain List" and "infant food-available strain List" (2022, 4) ", were adjusted )
The lactobacillus plantarum is applied to the preparation of foods or medicines for improving comprehensive performance in sports.
A food or medicine for improving sports comprehensive performance contains Lactobacillus plantarum as effective component.
A composition with comprehensive performance in improving exercise is prepared from the freeze-dried powder of lactobacillus plantarum and pea protein according to a mass ratio of 0.5-1: 99 to 99.5, wherein the viable count in the freeze-dried powder is more than or equal to 1.0x10 11 cfu/g。
Preferably, the ratio of the pea protein mass to the viable count of the lactobacillus plantarum contained in the freeze-dried powder is 20g: 1.0X10 10 cfu。
The invention has the beneficial effects that:
the invention provides a lactobacillus plantarum with comprehensive performance in improving exercise, and the lactobacillus plantarum is mixed with pea protein to prepare a composition. The composition has the effects of improving amino acid absorption rate, improving anaerobic power and muscle strength, and improving body constitution and muscle mass.
Drawings
FIG. 1 is a method of calculating muscle thickness;
fig. 2 is a method of calculating the thickness of muscle fascia.
Preservation information
Classification naming: lactobacillus plantarum TWK10
Latin Wen Xueming: lactobacillus plantarum
Preservation unit name: china general microbiological culture Collection center (China general microbiological culture collection center)
Deposit unit address: beijing city, chaoyang area, north Chenxi Lu No. 1 and 3
Preservation date: 2022, 6, 27
Preservation number: CGMCC No.25190
Detailed Description
The present invention will be further illustrated by the following examples, which are given by way of illustration only and are not intended to be limiting.
Test sample for experiment
1. Sample name and composition:
lactobacillus plantarum TWK10: lactiplantibacillus plantarum (Lactobacillus plantarum) TWK10 (the strain has been preserved in China general microbiological culture Collection center (China center for type culture Collection) for 6.27 days, with a preservation address of CGMCC No.25190, no. 3, north Chen West Lu No. 1, korea, beijing, city).
2. Test sample:
according to the purpose of the experiment, the experimental group was designed as follows:
(1) Control group (Control): pea protein without TWK10 (20 g/day).
(2) TWK10 group (TWK 10): containing TWK10 (1X 10) 10 CFU/day) pea protein (20 g/day).
3. The time of replenishment of the test sample:
(1) Untrained 4 days: and (5) drinking 2 hours before sleeping.
(2) Training for 3 days: after training, the beverage was drunk within 30 minutes (uniformly infused by laboratory).
(3) And analyzing the concentration of amino acid in blood, and immediately finishing drinking before on-site blood sampling.
(II) Experimental design and flow
1. Subject recruitment:
(1) Inclusion conditions: 32 are 20 to 45 years old, male and female halves, healthy, with exercise habits (exercise at least 3 times per week and at least more than 30 minutes each time).
(2) Exclusion conditions: smoking, drinking, cardiovascular disease, neuromuscular disease, metabolic disease, asthma, pregnant woman, lactation, BMI >30.
2. Experimental design and subject grouping:
at the time of recruitment of subjects, the subjects were investigated in what form of exercise they did at ordinary times, several times per week, several minutes each time, and after evaluation, those who reached inclusion condition were included in the protocol. The experiments were conducted using a double-blind design (double-blind) and subjects were randomized into 2 groups: (1) Pea proteins (Control) without TWK10, (2) TWK10 group (TWK 10). Two groups of subjects were supplemented with test samples for 28 consecutive days and were paired 3 exercises per week. The samples were subjected to exercise testing, blood and stool sample collection, body composition analysis and muscle mass analysis before and after intervention.
Each subject had to eat the test food (twk10+pea protein) or the control food (Pea protein) separately and a diet was recorded 3 days before the test and 3 days before the end of the recording after 4 weeks of sample intervention, and the calories ingested were calculated.
The subjects were kept on a normal diet and had to take nutritional supplements during the experiment and had to drink alcohol, eugerd, yandol, etc. probiotic-related products, e.g. and other medications, 1 week prior to exercise testing and blood drawing, to avoid affecting the experimental data.
Before and after testing and blood sampling, the subjects must be allowed to empty at least 8 hours before the test. And physical activities other than training are avoided 3 days before each exercise test.
(III) exercise training
Three exercises per week are all provided with professional exercise coaches and detailed training textbooks as shown in table 1.
Table 1 training class table
(IV) subject profile
Measuring the basic height, weight, resting heart rate and blood pressure of the subject.
(V) blood amino acid concentration
Blood samples were collected from subjects at 5 time points for 0, 30, 60, 120 and 180 minutes after pea protein supplementation, both before and at the end of the experiment. Centrifuging at 4deg.C and 12,000Xg for 15 min, collecting serum sample, adding ultrapure water with the same amount, mixing with amino acid isotope internal standard substance solution, adding isopropanol containing 1% formic acid, mixing, standing at-20deg.C for 20min, centrifuging to obtain supernatant, adding borate buffer (pH 8.6), mixing, adding AQC acetonitrile solution, and heating at 55deg.C for 10 min for derivatization. Finally diluted 100-fold with ultrapure water and analyzed by UPLC/MS/MS (Gray et al, 2017). The experiment was performed using a liquid chromatography tandem mass spectrometer (liquid chromatography tandem mass spectrometry, LC-MS/MS), wherein the liquid chromatography system was an Acquity UPLC, the column used was a Waters C18 column (2.1 x 150mm,1.8 μm), the temperature of the column was set at 45 ℃, the mobile phase used was water and 100% acetonitrile, both containing 0.1% formic acid by mass, the flow rate was 0.6mL/min, and the volume of the test solution injected was 2 μl. In addition, the tandem Mass spectrometer uses Xex TQ-S triple quadrupole Mass spectrometer as a Mass spectrometry mode, ESI+ parameters of 30 free amino acids are shown in Table 2, an ion pair with the highest signal intensity is selected as a quantitative ion, and data collection and quantitative calculation are performed by using Mass Lynx 4.1 software.
TABLE 2 ESI+ mode parameters for 30 free amino acids
The area under the amino acid concentration curved surface is calculated by a trapezoid formula to obtain [ (upper bottom: front time point + lower bottom: rear time point)/(time)/2 ], and the area under the amino acid concentration curved surface is calculated and summed up after individual calculation for 0-30min, 30-60min, 60-120min and 120-180 min. Cmax is the maximum concentration that was found at 5 time points in total of 0, 30, 60, 120 and 180 minutes after pea protein supplementation. Tmax is the time required to reach the maximum concentration, and thus the time at which the maximum value of the transmission Cmax is located is referred to as the Tmax value. The AUC and Cmax of BCAA, EAA, total amino acids are calculated by summing up the above terms. And Tmax for BCAA, EAA, total amino acids is averaged after summation.
Sixth athletic performance test
Wingate anaerobic test (Wingate Anaerobic test)
Full force sprinting was performed in 30 seconds using an anaerobic power cycle (894E,Monark Exercise AB,Sweden). At the beginning of the test, the test subjects were gradually increased to 120rpm, at which time a weight of 7.5% of the weight set (e.g., a 60 kg person would weigh 4.5 kg of resistance) would automatically fall onto the flywheel of the bicycle to create additional resistance, and the full force sprint was continuously required until 30 seconds. And recording the subject's fatigue index after testing using a motion conscious scale. The measured parameters are Mean power output, which is the power output average at the time of the test, relative Mean power (relative average power, i.e., average power/body weight), peak power, which is the Peak value of the output power during the test, maximum value, relative Peak power (relative Peak power, i.e., peak power/body weight), time to Peak power (which is the time taken from the start of the Peak power to reach during the test, the smaller the value the better the explosive force), fatigue index (Peak power minus valley power divided by Peak power, which indicates the greater the degree of power loss, the more fatigued), respectively.
2. Isotonicity test (Isometric Mid-Thigh, IMPT)
IMTP is a reliable and effective test that can be used to measure maximum force using custom IMTP test equipment (IMTP Rack, kairos Strength, USA) and a force plate (Type 9260aa, kistler, switzerland). All subjects stand equally wide apart with the bars placed between the thighs, the trunk upright, the spine neutral, the knee and hip angles 140 °, and the barbell pulled with maximum effort for 3-5 seconds. Before testing, the testers must be familiar with the IMPT test method, and the correct force and stable weight frequency are ensured through practice. Each test was repeated at 2 minute intervals to reduce detection errors associated with posture changes. The measured parameters are Peak Force (Peak Force, maximum Force), relative Peak Force (Peak Force relative, peak Force/body weight), pRFD (Force rate, i.e. [ Time spent starting motion To Peak Force increment/motion To Peak Force), time To Peak Force (i.e., time spent starting motion To Peak Force), time To Peak RFD (i.e., time spent starting motion To maximum Force rate), respectively.
3. Horizontal speculation test (One repetition maximum (1-RM) test Press test)
The device used was a smith machine (MG-PL 62, matrix Fitness, USA), the test mode was specified to the subject before the test, and sufficient warming should be performed. For example, at least 5-10 light to medium weight actions should be performed. After calm, the subject should rest for two to four minutes before any horizontal conjecture trial is attempted. The subject first lies flat on the bench with his feet flat on the floor and his buttocks and shoulders in contact with the bench. The distance to hold the barbell is slightly wider than the shoulder width (so that the elbow is at right angles to the lowest point). The test typically begins with the arms fully extended, placing weight directly over the chest. The weight descends at a controlled rate and with a smooth motion, just touching the chest, and then returns to the starting position. The maximum bench press test, the upper body muscle strength endurance test, was used with resistance set to a percentage of body weight and increased to the maximum muscle strength that the subject can produce with a single contraction.
Seven musculoskeletal ultrasound scanning measurements
The muscle thickness, fascia change length of Biceps Brachii muscle and Quadriceps femoris muscle were scanned using an ultrasonic scanner (H1300, BENQ, taipei, taiwan) and the detailed examination was as follows: measurement position reference (Mah & van Alfen, 2018) study, please first show that the experimental participant is lying down, the palms of both hands are upwards to present anatomical positions, biceps Brachii muscle measurement position is the straight line distance from the Acromion (Acromion) to the elbow transverse line (Antecubital crease), and the ultrasonic probe placement position is 1/3 of the distance from the elbow transverse line; quadriceps femoris muscle the probe is placed at a distance of 1/2 of the straight line from the anterior superior iliac spine (Anterior superior iliac spine, ASIS) to the superior border of the Patella (Patella). Data analysis was performed using ImageJ version 2.3.0/1.53f (National Institutes of Health, bethesda, maryland, USA). The muscle thickness analysis method is to calculate the sum of the thicknesses of the two ends of the muscle and divide the sum by two, as shown in fig. 1. Reference for muscular fascia calculation method (Nakamura et al 2011), calculation method is: muscle thickness Sin (θ), θ is the angle between the fascia and the horizontal line, as shown in fig. 2. The calculation method of the thickness of the muscle and the thickness variation of the muscle fascia is (thickness measured later-thickness measured earlier) =thickness variation.
Eight double-energy X-ray absorption bone density examination room
The X-ray transmitted through the detected part is received by the scintillation detector, and the obtained data is analyzed by the computer to calculate the muscle mass, body fat and bone density, and the muscle mass, body fat and bone density values of the detected person are compared with the computer report to make a diagnosis. This examination measures the muscle mass, body fat and bone density of the whole body, and the time required for each examination is reduced from 25 minutes to 10 minutes per site. In addition, examination of the patient with DEXA (Lunar iDXA, GE Healthcare, chicago, IL, USA) was performed to obtain about 1/100 of the exposure to a chest X-ray, which was quite safe. This examination is currently the most popular and popular instrument for measuring muscle mass, body fat and bone density due to its high speed, accuracy, sensitivity, ease of handling and non-invasive nature.
Nine personal intensity checklists (Checklist individual strength, CIS), fatigue vision scale (Visual analog fatigue scale, VAFS) and athletic subjective intensity scale (Rating of perceived exertion, RPE)
Four orientations for fatigue assessment were performed through a personal intensity checklist questionnaire: fatigue, attention, power and mobility. The scoring modes of each item of topic are as follows: a score of 1 is very good for-7 is very bad for, and so on. Wherein, 1, 3, 4, 9, 10, 13, 14, 16, 17, 18, 19 are entitled reverse questions, and are scored in reverse: a score of 1 is very non-conforming to a score of 7 is very conforming. The score totals of questions 1, 4, 6, 9, 12, 14, 16, and 20 are expressed as a score representing the degree of fatigue experienced by the subject; taking the total score of the questions 3, 8, 11, 13 and 19 as a sub-scale II, and representing the concentration degree; taking the total score of the questions 2, 5, 15 and 18 as a sub-scale three, and representing the score of the degree of the exercise; the score of questions 7, 10 and 17 is taken as a sub-scale IV and represents the score of the physical activity degree; further, the total of the scores of the questions 1 to 20 was calculated as the individual fatigue strength score, and a higher score indicates a fatiguer.
Before and after the exercise, a fatigue vision analog meter is carried out, a straight line with the actual length of 100mm is marked on the leftmost side, 0mm is marked on the rightmost side, 100mm is marked on the rightmost side, 0mm is interpreted to a subject to represent no fatigue, 100mm represents very high fatigue, the left end moves to the right to represent more and more fatigue, the subject draws a short line on the straight line vertically by taking a pen, then the measured cm value is recorded, and the value is converted into 0-100 minutes to be displayed. The graphic rating scale is one of the rating scales, and has the greatest characteristic that each characteristic or quality is represented by a horizontal line. The assessment method is to mark on-line. Typically, a few vertical lines are added to the line segment, and each intersection represents a category of different degrees, expressed as a total of 5 points without fatigue, mild, moderate, severe, and very tired. The numerical evaluation scale indicates that the fatigue degree is relaxed by the number of 1-10, and the higher the score is, the more fatigue is indicated.
In addition, subjective exercise fatigue feeling was also recorded by the exercise subjective intensity scale.
(ten) statistical analysis
All values are expressed as mean±sd, 16 subjects per group; analysis was performed using the statistical package software SPSS Statistics 25. Comparing before and after the intervention in the group, and if the data is parametric, adopting a Paired Student's t test; if the data is non-parametric, wilcoxon signed-rank test is used. For comparison between groups, unpaired Student's t test is used for data for parametric; the data were verified using Mann-Whitney U test for non-parameter. P <0.05 represents a significant difference.
The general characteristics and exercise habits of the subjects are shown in tables 3-1 and 3-2, and the results are shown in tables 4-9.
TABLE 3-1 general characteristics of the subject
TABLE 3-2 exercise habit of subject
TABLE 4 area under the curve (AUC) for individual amino acids, BCAA, EAA and total amino acids
Data are shown as mean ± standard deviation. Analysis of treatment effect by unpaired student t-test P<0.05,***P<0.001. Differences between groups before and after dosing were analyzed by paired student t-test. #P (#P)<0.05,###P<0.01,###P<0.001. Changes in AUC were analyzed using the Mann-Whitney U test.
TABLE 5 maximum concentrations of individual amino acids, BCAA, EAA and total amino acids (C max )
Data are shown as mean ± standard deviation. Analysis of treatment effect by unpaired student t-test P<0.05,***P<0.001. Differences between groups before and after dosing were analyzed by paired student t-test. #P (#P)<0.05,###P<0.01,###P<0.001. Changes in AUC were analyzed using the Mann-Whitney U test.
TABLE 6 time to maximum concentration (Tmax) of individual amino acids, BCAA, EAA and total amino acids
TABLE 7 muscle thickness and fascia thickness of subject
Data are shown as mean ± SD. Treatment effect was analyzed by unpaired student t-test. P <0.05 was analyzed by paired student t-test for differences before and after dosing for each group,
**P<0.01,***P<0.001. the change in muscle thickness was calculated as the difference between before and after administration and analyzed for statistical significance using the Mann-Whitney U test. P<0.001。
TABLE 8 physical Condition changes in a subject
TABLE 9 personal force (CIS) questionnaire checklist
Data are shown as mean ± standard deviation. The therapeutic effect was analyzed by Mann-Whitney U test. Differences between groups before and after dosing were analyzed by Wilcoxon signed rank test.The numerical changes were calculated from the differences before and after dosing and analyzed for statistical significance using the Mann-Whitney U test. #P (#P)<0.05。.
The sport lactobacillus TWK10 can obviously increase the peak value and the maximum stress rate of the isotonic muscle strength compared with the prior intervention after being supplemented for four weeks continuously in the isotonic muscle strength expression part.
The athletic lactobacillus TWK10 can significantly increase the performance of the lying-pushing muscle strength after being supplemented for four weeks in the muscle strength performance part compared with the prior intervention.
The lactic acid bacteria TWK10 can significantly increase muscle thickness after continuous four-week supplementation of body components compared to prior to intervention.
Thus, the applicant believes that 20g of pea protein is supplemented per day with Lactobacillus kinesis TWK10 (1X 10) 10 CFU/day) in combination with three times per week resistance exercise training, with:
(1) Is helpful for improving the absorption rate of total BCAA, total EAA and total amino acid in blood;
(2) The maximum muscle strength, the isotonicity, the anaerobic power and other athletic performances are improved;
(3) Helping to increase muscle thickness.
While the foregoing describes the embodiments of the present invention, it is not intended to limit the scope of the present invention, and various modifications or variations may be made by those skilled in the art without the need for inventive effort on the basis of the technical solutions of the present invention.
Claims (4)
1. Lactobacillus plantarum (Lactobacillus plantarum) TWK10 with comprehensive performance in the aspect of improving exercise is characterized in that the strain is preserved in China general microbiological culture Collection center (China center for type culture Collection) for 6 months and 27 days in 2022, wherein the preservation address is North Chen Xili No. 1 and 3 in the Korean region of Beijing city, and the preservation number is CGMCC No.25190.
2. Use of lactobacillus plantarum according to claim 1 for the preparation of a food or a medicament for improving the overall performance of sports.
3. A food or medicament for improving the comprehensive performance of sports, characterized in that the effective component is the lactobacillus plantarum of claim 1.
4. A composition for improving the overall performance of sports, characterized in thatThus, the mass ratio of the freeze-dried powder of the lactobacillus plantarum to the pea protein is 0.5-1: 99 to 99.5, wherein the viable count in the freeze-dried powder is more than or equal to 1.0x10 11 cfu/g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211589419.6A CN116286462A (en) | 2022-12-11 | 2022-12-11 | Lactobacillus plantarum with comprehensive performance in motion improvement and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211589419.6A CN116286462A (en) | 2022-12-11 | 2022-12-11 | Lactobacillus plantarum with comprehensive performance in motion improvement and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116286462A true CN116286462A (en) | 2023-06-23 |
Family
ID=86782229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211589419.6A Pending CN116286462A (en) | 2022-12-11 | 2022-12-11 | Lactobacillus plantarum with comprehensive performance in motion improvement and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116286462A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180055893A1 (en) * | 2016-08-24 | 2018-03-01 | National Taiwan Sport University | Use of lactobacillus plantarum composition for manufacturing anti-fatigue probiotic composition for improve exercise performance |
CN111567796A (en) * | 2020-05-27 | 2020-08-25 | 山东探克生物科技股份有限公司 | Sports nutritional probiotic composition and preparation method thereof |
CN113116937A (en) * | 2019-12-30 | 2021-07-16 | 生合生物科技股份有限公司 | Use of Lactobacillus plantarum for maintaining and/or improving muscle mass and/or muscle strength in elderly individuals and for the treatment of sarcopenia |
-
2022
- 2022-12-11 CN CN202211589419.6A patent/CN116286462A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180055893A1 (en) * | 2016-08-24 | 2018-03-01 | National Taiwan Sport University | Use of lactobacillus plantarum composition for manufacturing anti-fatigue probiotic composition for improve exercise performance |
CN113116937A (en) * | 2019-12-30 | 2021-07-16 | 生合生物科技股份有限公司 | Use of Lactobacillus plantarum for maintaining and/or improving muscle mass and/or muscle strength in elderly individuals and for the treatment of sarcopenia |
CN111567796A (en) * | 2020-05-27 | 2020-08-25 | 山东探克生物科技股份有限公司 | Sports nutritional probiotic composition and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
林金生等: "补充植物乳杆菌TWK10 可以提升运动表现及增加肌肉量", 第14届益生菌与健康国际研讨会摘要集, pages 113 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Antonio Paoli et al. | Effects of 30 days of ketogenic diet on body composition, muscle strength, muscle area, metabolism, and performance in semi-professional soccer players | |
Almeida et al. | Nutritional and anthropometric profile of adolescent volleyball athletes | |
Kerksick et al. | Impact of differing protein sources and a creatine containing nutritional formula after 12 weeks of resistance training | |
Zbinden-Foncea et al. | Effects of caffeine on countermovement-jump performance variables in elite male volleyball players | |
Moslehi et al. | Does magnesium supplementation improve body composition and muscle strength in middle-aged overweight women? A double-blind, placebo-controlled, randomized clinical trial | |
Dawson et al. | Effects of 4 weeks of creatine supplementation in junior swimmers on freestyle sprint and swim bench performance | |
Kim et al. | The effect of an exercise program on body composition and physical fitness in obese female college students | |
Vashchuk et al. | The realization of the individual fitness programs in the physical education of high schoolgirls | |
Kim et al. | The additive effects of exercise and essential amino acid on muscle mass and strength in community-dwelling older Japanese women with muscle mass decline, but not weakness and slowness: A randomized controlled and placebo trial | |
CN116286462A (en) | Lactobacillus plantarum with comprehensive performance in motion improvement and application thereof | |
Asadi et al. | Effects of combined resistance-aerobic training and milk consumption on the weight loss of overweight female students | |
Dawes et al. | The effects of a pre-workout energy drink on measures of physical performance | |
Ativie et al. | Modulations of 8-Week Aerobic Dance Exercise on Selected Anthropometric Indicators in Overweight and Obese Females | |
Zhu et al. | Influence of Aerobics Exercises on Physical Health of Obese College Students under the Background of Physical and Medical Integration. | |
Messina et al. | Effects of protein supplementation in fitness world: A 12-week cross-over studio | |
Effendi et al. | The Effect Of Giving Soy Flour And Lunges Exercises On The Ability Of Kick Speed In Front Of Pencak Silat Athletes Of The Center For Education And Sports Training (PPLP) Of West Sumatra | |
Rossiou et al. | Energy expenditure and nutrition status of ballet, jazz and contemporary dance students | |
Daneshyar et al. | Effect of yoga with and without elastic band resistance training on visfatin, liver enzymes and body composition in postmenopausal women | |
Kim et al. | The Effects of 12-week Instrumental Pilates on Isokinetic Muscular Function and Body Composition in College Women | |
Faridah | The Effect of Obesity and Flexibility Toward Women’s Body Fat in Productive Age at Larasati Gymnastic Semarang Member | |
Qiao et al. | The effects of elastic band resistance training on the physical activities, strength, body composition, and quality of life of the elderly | |
Darzabi et al. | Comparing the effect of eight weeks selected football practice and corrective movements on abnormalities and body composition in students | |
Munson | Some effects of anabolic steroids during weight training | |
Fuchs et al. | Becoming a World Champion Powerlifter at 71 Years of Age: It Is Never Too Late to Start Exercising | |
Nongkhai et al. | Online Resistance Training for Anthropometric Parameters and Muscle Strength in Overweight Female Adolescents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20230623 |
|
RJ01 | Rejection of invention patent application after publication |